<DOC>
	<DOC>NCT01417078</DOC>
	<brief_summary>The purpose of this study is to determine the pharmacokinetics of Diazepam Nasal Spray following a single dose in epileptic patients experiencing a seizure episode.</brief_summary>
	<brief_title>A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Diazepam</mesh_term>
	<criteria>Provide signed informed consent for study participation. General good health with no clinically significant unstable abnormalities. Diagnosis of epilepsy. Individuals receiving warfarin (Coumadin®) or dabigatran (Pradaxa®). Use of any investigational drug within 30 days. Blood or plasma donation within 30 days. Not willing or unable to tolerate blood draws.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>